<DOC>
	<DOCNO>NCT00539851</DOCNO>
	<brief_summary>This study propose investigate incidence Post Transplant Diabetes Mellitus ( PTDM ) well associate risk factor development PTDM patient undergo allogenic stem cell transplantation .</brief_summary>
	<brief_title>Risk Factors Diabetes After Stem Cell Transplantation</brief_title>
	<detailed_description>Allogenic stem cell transplantation relate unrelated donor use successfully cure patient variety hematological malignancy . Graft-versus-host disease ( GVHD ) alloreactive immune phenomenon , activate donor T cell recognize recipient foreign effect cytotoxic response . GVHD occur first 100 day transplantation term acute GVHD characterize hepatitis , dermatitis , enteritis . High dose corticosteroid remain one cornerstone therapies treat acute GVHD . However , association corticosteroid therapy development diabetes mellitus solid organ transplantation become widely recognize . Similarly , post transplant diabetes mellitus ( PTDM ) increasingly note allogenic stem cell transplant population , however , date , systematic study complete identify incidence PTDM associate risk factor . We propose investigate incidence PTDM well associate risk factor development PTDM patient undergo allogenic stem cell transplantation .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>18 65 year age Fulfills institutional criterion schedule undergo allogenic stem cell transplantation VUMC Younger 18 year old 65 year Preexisting diabetes mellitus Positive pregnancy test Unable complete conditioning regimen prior stem cell transplantation Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Allogenic Stem Cell Transplantation</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>